Chronopharmacokinetics of Cyclosporine A in the Wistar rat following oral administration
- PMID: 1425812
- DOI: 10.1007/BF03188782
Chronopharmacokinetics of Cyclosporine A in the Wistar rat following oral administration
Abstract
The pharmacokinetics of Cyclosporine A (CsA) was studied in male Wistar rats weighting 300 +/- 50 g trained to a 12:12 light-dark cycle. Oral administration (40 mg/kg) was performed at 1 of 4 different temporal stages: 09.00 h, 15.00 h, 21.00 h or 03.00 h (local time) i.e. 0200, 0800, 1400 or 2000 HALO (hours after light on). Blood samples were collected over 72-96 h after dosing, plasma was separated by centrifugation at 37 degrees C and stored frozen until assay, using radioimmunoassay (RIA). Two experiments were performed: the first with 4 groups of 48 rats and a non-specific polyclonal antibody (P-RIA); and the second with only 2 groups of 48 rats and a more specific monoclonal antibody (M-RIA). Plasma concentration data were evaluated with model-based linear pharmacokinetic concepts, with apparent zero-order or first-order absorption and n-exponential disposition (n = 1, 2 or 3): models MN0 or MN1. A compartment-independent approach was also conducted and led to area under the plasma concentration-time curve (AUC) and mean residence time (MRT) determinations. A comparison of the pharmacokinetic profiles across time of administration indicates that absorption, first-pass metabolism and tissue distribution of CsA in the rat are circadian-dosing stage dependent.
Similar articles
-
[The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].Yao Xue Xue Bao. 2006 Sep;41(9):882-7. Yao Xue Xue Bao. 2006. PMID: 17111838 Chinese.
-
Effect of probucol on the oral bioavailability of cyclosporine A.Eur J Pharm Sci. 2004 May;22(1):71-7. doi: 10.1016/j.ejps.2004.02.009. Eur J Pharm Sci. 2004. PMID: 15113585
-
Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.Int J Pharm. 2008 Mar 3;351(1-2):8-14. doi: 10.1016/j.ijpharm.2007.09.011. Epub 2007 Sep 15. Int J Pharm. 2008. PMID: 17954018
-
Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.Xenobiotica. 2006 Sep;36(9):838-56. doi: 10.1080/00498250600839369. Xenobiotica. 2006. PMID: 16971347
-
Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.Clin Pharmacokinet. 2002;41(1):59-69. doi: 10.2165/00003088-200241010-00005. Clin Pharmacokinet. 2002. PMID: 11825097 Clinical Trial.
Cited by
-
Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients.Transplant Direct. 2023 Feb 8;9(3):e1448. doi: 10.1097/TXD.0000000000001448. eCollection 2023 Mar. Transplant Direct. 2023. PMID: 36875939 Free PMC article.
-
Chronopharmacokinetics of ciclosporin and tacrolimus.Clin Pharmacokinet. 2006;45(8):775-88. doi: 10.2165/00003088-200645080-00002. Clin Pharmacokinet. 2006. PMID: 16884317 Review.